Hippocratic AI corrects claim that Polaris 5.0 outperforms every frontier model, revises to "major" frontier models

Hippocratic AI released Polaris 5.0, a voice AI for clinical settings that scored 99.95% on drug safety tasks versus 87.9% for the nearest competitor. It responds in 1.5 seconds, fast enough for live patient calls.

Categorized in: AI News Healthcare
Published on: May 02, 2026
Hippocratic AI corrects claim that Polaris 5.0 outperforms every frontier model, revises to "major" frontier models

Hippocratic AI Releases Polaris 5.0 Healthcare Model, Claims Speed and Safety Advantages Over Competitors

Hippocratic AI announced Polaris 5.0, a voice AI system built specifically for clinical settings. The model outperforms general-purpose AI systems from OpenAI, Anthropic, and Google on medical tasks including drug safety verification, clinical escalation, and regulatory compliance, according to the company's benchmarks.

The system runs at 1.5 seconds time-to-first-audio, making it fast enough for real-time patient conversations. By comparison, frontier thinking models from OpenAI (GPT 5.4 Pro), Anthropic (Claude Opus 4.7), and Google (Gemini 3.1 Pro) were marked "too slow for voice" in testing.

What's built into Polaris 5.0

The model is a 5-trillion-parameter constellation powered by a 700-billion-parameter core. It includes a custom speech-to-text system tuned for drug names and medical terminology, and custom text-to-speech designed for medication pronunciation consistency.

New clinical features include:

  • Cough and throat-clearing detection for respiratory assessment
  • Drug safety checks covering contraindications, dosages, and brand-to-generic mapping
  • Clinical escalation across seven body systems (musculoskeletal, neurological, cardiovascular, respiratory, gastrointestinal, genitourinary, wound and skin, mental health)
  • Multi-document retrieval that cross-references insurance formularies and benefits in a single conversation turn
  • Mid-call language switching between English, Spanish, and Mandarin without context loss
  • HIPAA-compliant authentication and CMS plan benefit verification

Benchmark results

Polaris 5.0 scored 99.95% on drug safety tasks. The closest competitor, GPT 5.4 Mini, scored 87.9%. On clinical escalation safety across seven body systems, Polaris 5.0 achieved 99.75%, compared to Gemini 2.5 Flash at 91.3%.

For HIPAA-compliant authentication, Polaris 5.0 reached 99.1% accuracy. Gemini 2.5 Flash scored 80.6%. On CMS guideline adherence, Polaris 5.0 achieved 92.0%, while Claude 4.5 Haiku scored 61.0%.

The company tested conversational skills including handling patient skepticism and non-linear medical intake. Polaris 5.0 scored 96.2% on skepticism handling versus 72.2% for Gemini 2.5 Flash, and 99.3% on non-linear intake versus 96.5% for Claude 4.5 Haiku.

Clinical validation

Hippocratic AI trained the model on more than 180 million real patient interactions and validated it with U.S.-licensed clinicians. Earlier versions of Polaris achieved 99.89% correct clinical guidance with zero severe harm events, the company said, based on feedback from more than 7,500 clinicians.

The system is already deployed with health systems, payers, and pharmaceutical companies across the United States.

Learn more about AI for Healthcare and Generative AI and LLM technologies.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)